Publication

Article

BioPharm International

BioPharm International-08-15-2014
Volume2014 eBook
Issue 2

Keys to Successful Method Transfer

Author(s):

Cynthia A. Challener

Methods must be suitable at each development phase, robust, and effective on multiple platforms.

 

Methods must be suitable at each development phase, robust, and effective on multiple platforms.
 

Read this article

from BioPharm International’s 2014 Analytical and Bioanalytical eBook.

 

 

 

 

 

 

 

 

Articles in this issue
BPsupp0814_Method_TransferR1_200.jpg
Keys to Successful Method Transfer
BPsupp0814_Viral_Contam_200.jpg
The Challenge of Finding the Unknown
BPsupp0814_SGSR1_200.jpg
Testing the Quality, Safety, and Efficacy of Insulin Biosimilars
BPsupp0814_biorad_200.jpg
Using the Purity Quotient Difference to Assess Protein Purification
BPsupp0814_Allotrope_200.jpg
Standardizing Data Management

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Behind the Headlines, Episode 23: Patent Cliff Deals, Tariff Pressures, and the In Vivo Cell Therapy Bet
Related Content
Binary code and lock shape on pixellated screen | Image Credit: © JohanSwanepoel - © JohanSwanepoel - stock.adobe.com
September 15th 2025

PDA 2025: Data Governance and AI's Impact on Drug Manufacturing

Feliza Mirasol
Loading a DNA tube into a PCR (polymerase chain reaction) thermocycler machine in a bioscience laboratory. Concept of science, laboratory and study of diseases. Coronavirus (COVID-19) treatment | Image Credit: © dhvstockphoto - © dhvstockphoto - stock.adobe.com
September 15th 2025

CGT Diagnostic Testing Partners Require Pioneering Spirit in Rapidly Evolving Landscape

Phil Robertson
small interfering RNA bound to a messenger RNA, cartoon model with semi-transparent surface. siRNAs are synthetic RNA interference tools used for inducing temporary reduction of mRNA expression. | Image Credit: © petarg - © petarg - stock.adobe.com
September 15th 2025

Hongene Expands exNA Technology Access for RNA Therapeutics Research with New Licensing Deal

Feliza Mirasol
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
September 15th 2025

European TICC group, Normec, Gains Foothold in US Market with Three Strategic Acquisitions

Feliza Mirasol
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
September 15th 2025

Roche Divulges New Alzheimer’s Disease Research Data at AAIC 2025

Feliza Mirasol
3D rendered laboratory test tubes with fluorescent green positive results in uv light | Image Credit: ©mguido - stock.adobe.com
September 15th 2025

Mechanistic Hypothesis of Toxicity: Driving Decision Making in Preclinical Translation

Stefan Foser Steve Castellino
© 2025 MJH Life Sciences

All rights reserved.